New fee regulation: General questions and answers for human medicinal products - Annex I
New fee regulation: General questions and answers for human medicinal products - Annex I
New fee regulation: General questions and answers for human medicinal products - Annex I
Human medicines European public assessment report (EPAR): Cystagon, mercaptamine bitartrate, Date of authorisation: 23/06/1997, Revision: 20, Status: Authorised
Kexxtone
EMA communication perception survey report 2024
Summary of opinion: Flucelvax Tetra, 12/12/2024 Positive
2024 annual workshop of the European network of paediatric research at EMA (Enpr-EMA) , Online, European Medicines Agency, Amsterdam, the Netherlands, from 2 October 2024, 09:00 (CEST) to 2 October 2024, 17:00 (CEST)
European Shortages Monitoring Platform (ESMP): Stakeholder engagement plan
Methodology European Specialised Expert Community (ESEC): Members
Three-year rolling work plan for the Quality Innovation Group (QIG) 2025-2027
Clinical trial information system (CTIS) public portal full trial information